Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific
- PMID: 21071386
- PMCID: PMC3304520
- DOI: 10.1093/ije/dyq192
Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific
Figures
References
-
- Joint United Nations Programme on HIV/AIDS and World Health Organization. AIDS Epidemic Update 2009. Geneva, Switzerland: http://data.unaids.org/pub/Report/2009/JC1700_Epi_Update_2009_en.pdf (1 July 2010, date last accessed)
-
- World Health Organization. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector: Progress Report 2009. http://www.who.int/hiv/pub/tuapr_2009_en.pdf (1 July 2010, date last accessed)
-
- Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817–24. - PubMed
-
- Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis. 2005;41:217–24. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
